Search research articles
Contact Us
Filters
Showing results (1071-1080 of 1,443) with videos related to
Page
of 145
Sort By:
Oral Oncology
|
July 27, 2019
Polymorphous adenocarcinoma of salivary glands
Ximena Mimica, Nora Katabi, Marlena R McGill, et al.
Endoscopy International Open
|
April 18, 2022
Yield of upper gastrointestinal screening in colonic adenomatous polyposis of unknown etiology: a multicenter study
Filsan Farah, Swati G Patel, Jeannine M Espinoza, et al.
Oral Oncology
|
June 11, 2019
Sex disparities in salivary malignancies: Does female sex impact oncological outcome?
Ximena Mimica, Marlena McGill, Ashley Hay, et al.
American Journal of Community Psychology
|
March 11, 2025
"We're all about being together as a family": Community sports program fosters newcomer immigrant girls' academic achievement, resilience, and coping
Sarah E Tilzey, Jordan J Cramer, Swapandeep S Mushiana, et al.
AIDS (London, England)
|
July 9, 2010
Similar efficacy and tolerability of atazanavir compared with atazanavir/ritonavir, each with abacavir/lamivudine after initial suppression with abacavir/lamivudine plus ritonavir-boosted atazanavir in HIV-infected patients
Kathleen E Squires, Benjamin Young, Edwin Dejesus, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
January 18, 2006
Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx
Ian Ganly, Snehal G Patel, Jeannette Matsuo, et al.
Cancer Immunology, Immunotherapy : CII
|
September 11, 2020
Next-generation humanized patient-derived xenograft mouse model for pre-clinical antibody studies in neuroblastoma
Rosa Nguyen, Anand G Patel, Lyra M Griffiths, et al.
The British Journal of Surgery
|
October 30, 2015
Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection
I J Nixon, L Y Wang, I Ganly, et al.
Cancer
|
August 18, 2015
Cost-effectiveness analysis of papillary thyroid cancer surveillance
Laura Y Wang, Benjamin R Roman, Jocelyn C Migliacci, et al.
Cancer Chemotherapy and Pharmacology
|
June 12, 2017
TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies
Howard A Burris, C D Kurkjian, L Hart, et al.
Page
of 145
Search research articles
Search
Showing results (1071-1080 of 1,443) with videos related to
Sort By:
Page
of 145
Oral Oncology
|
July 27, 2019
Polymorphous adenocarcinoma of salivary glands
Ximena Mimica, Nora Katabi, Marlena R McGill, et al.
Endoscopy International Open
|
April 18, 2022
Yield of upper gastrointestinal screening in colonic adenomatous polyposis of unknown etiology: a multicenter study
Filsan Farah, Swati G Patel, Jeannine M Espinoza, et al.
Oral Oncology
|
June 11, 2019
Sex disparities in salivary malignancies: Does female sex impact oncological outcome?
Ximena Mimica, Marlena McGill, Ashley Hay, et al.
American Journal of Community Psychology
|
March 11, 2025
"We're all about being together as a family": Community sports program fosters newcomer immigrant girls' academic achievement, resilience, and coping
Sarah E Tilzey, Jordan J Cramer, Swapandeep S Mushiana, et al.
AIDS (London, England)
|
July 9, 2010
Similar efficacy and tolerability of atazanavir compared with atazanavir/ritonavir, each with abacavir/lamivudine after initial suppression with abacavir/lamivudine plus ritonavir-boosted atazanavir in HIV-infected patients
Kathleen E Squires, Benjamin Young, Edwin Dejesus, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
January 18, 2006
Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx
Ian Ganly, Snehal G Patel, Jeannette Matsuo, et al.
Cancer Immunology, Immunotherapy : CII
|
September 11, 2020
Next-generation humanized patient-derived xenograft mouse model for pre-clinical antibody studies in neuroblastoma
Rosa Nguyen, Anand G Patel, Lyra M Griffiths, et al.
The British Journal of Surgery
|
October 30, 2015
Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection
I J Nixon, L Y Wang, I Ganly, et al.
Cancer
|
August 18, 2015
Cost-effectiveness analysis of papillary thyroid cancer surveillance
Laura Y Wang, Benjamin R Roman, Jocelyn C Migliacci, et al.
Cancer Chemotherapy and Pharmacology
|
June 12, 2017
TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies
Howard A Burris, C D Kurkjian, L Hart, et al.
Page
of 145